Mohammed Oukkal

3PUBLICATIONS
20CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 08, 2022
Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.

Asma-Lamia Boumehdi, Farid Cherbal, Feriel Khider

|Jan 21, 2022
An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction.

İrfan Cicin, Mohammed Oukkal, Hassen Mahfouf

|Jun 04, 2021
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay-Results From the SAFIA Phase III Trial.

Khalid AlSaleh, Heba Al Zahwahry, Adda Bounedjar

Pageof 1

Frequent Collaborators

2 joint publications

Khalid AlSaleh

1 joint publications

Assia Bensalem

1 joint publications

Hikmat Abdel-Razeq

1 joint publications

Alaa Kandil